Patients with metastatic colorectal cancer who were treated with a biweekly dose of trifluridine-tipiracil (TAS-102) saw ...

Results for IRAKLIA show noninferiority for Sanofi's on-body delivery system for isatuximab, compared with IV administration.

The purpose of this study is to assess the effectiveness of daratumumab SC in treating patients with ... first within 10 to 14 days prior to dosing and the second within 24 hours prior to dosing; A ...